InvestorsHub Logo
Followers 15
Posts 1594
Boards Moderated 0
Alias Born 07/22/2005

Re: Lady-baron post# 323361

Monday, 09/08/2014 8:44:46 AM

Monday, September 08, 2014 8:44:46 AM

Post# of 658231
MSTX Mast Therapeutics Announces Positive Top Line Results From Phase 2 Study Of AIR001 For Pulmonary Arterial Hypertension And AIR001 Clinical Development Plan
- Data show improvements in hemodynamic parameters and exercise capacity
- AIR001 well-tolerated, with no treatment-related serious adverse events
- Data support further clinical development in pulmonary hypertension (PH)
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.